NCT02092571View on ClinicalTrials.gov

A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pharmacokinetics
Interventions
DRUG

Progesterone vaginal ring,

Participants will be randomized to receive treatments in 1 of 2 treatment sequences (AB or BA)

Trial Locations (1)

Unknown

Teva Investigational Site 12355, Miami

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT02092571 - A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women | Biotech Hunter | Biotech Hunter